| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.001 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |